§432E-4 Enrollee participation in treatment decisions. (a) An enrollee shall have the right to be informed fully prior to making any decision about any treatment, benefit, or nontreatment.
(b) In order to inform enrollees fully, the provider shall:
(1) Discuss all treatment options with an enrollee, as provided by section 671-3, including the option of no treatment at all;
(2) Ensure that persons with disabilities have an effective means of communication with the provider and other members of the managed care plan; and
(3) Discuss all risks, benefits, and consequences to treatment and nontreatment, as provided by section 671-3(b).
(c) The provider shall discuss with the enrollee and the enrollee's immediate family both [advance] health-care directives, as provided for in chapter 327E, and durable powers of attorney in relation to medical treatment.
(d) A managed care plan shall be prohibited from imposing any type of prohibition, disincentive, penalty, or other negative treatment upon a provider for discussing or providing any information regarding treatment options and medically necessary or appropriate care, including no treatment, even if the information relates to services or benefits not provided by the managed care plan. [L 1998, c 178, pt of §2; am L 2003, c 114, §1; am L 2005, c 22, §30; am L 2014, c 22, §3]
Structure Hawaii Revised Statutes
432E. Patients' Bill of Rights and Responsibilities Act
432E-1.5 Licensure of managed care plan medical directors.
432E-2 Conflict with other laws.
432E-4 Enrollee participation in treatment decisions.
432E-5 Complaints and appeals procedure for enrollees.
432E-6.5 Expedited internal appeal, when authorized; standard for decision.
432E-7 Information to enrollees.
432E-10 Managed care plan performance measurement and data reporting standards.
432E-11 Accreditation of managed care plans.
432E-31 Applicability and scope.
432E-32 Notice of right to external review.
432E-33 Request for external review.
432E-34 Standard external review.
432E-35 Expedited external review.
432E-36 External review of experimental or investigational treatment adverse determinations.
432E-37 Binding nature of external review decision.
432E-38 Approval of independent review organizations.
432E-39 Minimum qualifications for independent review organizations.
432E-40 Hold harmless for independent review organizations.
432E-41 External review reporting requirements.
432E-42 Funding of external review.